Clinical Medicine Insights-Oncology

Papers
(The H4-Index of Clinical Medicine Insights-Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects41
The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors31
Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer18
Radiomics in Nasopharyngeal Carcinoma14
Radiation-Induced Fibrosis in Patients with Head and Neck Cancer: A Review of Pathogenesis and Clinical Outcomes14
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer13
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)11
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition11
Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges10
0.021139144897461